Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences, AnaSpec

Premium
Pressure BioSciences this week launched ProteoSolveLRS, its first pressure cycling technology-dependent research-use only kit for extracting proteins from lipid-rich samples. Earlier this month, the company announced the development of the PCT-dependent method. In a statement, Pressure BioSciences said the method offers significant advantages over current extraction techniques, including the ability to use certain organic solvents instead of harsh detergents in the extraction process.
 

 
AnaSpec introduced its new Rabbit Anti-MOG (35-55) antibody this week. The polyclonal antibody was raised against a synthetic peptide from the N-terminus corresponding to amino acids 35-55 of mouse and rat MOG, the company said in a statement.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.